论文信息 - A phase IB/IIA study of remestemcel‐L, an allogeneic bone marrow‐derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysis - 字舞流文

A phase IB/IIA study of remestemcel‐L, an allogeneic bone marrow‐derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysis

S. Steele | A. Lightner | Neda Dadgar | Clifton G Fulmer | Justin Ream | D. Nachand | Caroline Matyas | Kavita Elliott | Neha Khaitan | Clifton G. Fulmer | N. Dadgar